A couple points. The 3 million is a great cash infusion for the company to expand without the need to dilute. Our CEO is a financial wizard that knows how to get things done and where to find capital through his resourcefulness and financial savvy. Most other OTC companies would just take the easy way and dilute to raise funds and that is what makes NRTI so different.
Yes it will come down to sales in the end, but being that the company just launched the Martha Stewart Essentials line in September and that Oct - Dec is the lowest season for these type of sales, it wouldn't be very practical or logical to expect huge sales during this period. However, Jan - March is the peak season and that is where we will really find out how these products are selling.
The MSE line has only been available for a little over 3 months with limited distribution and very limited advertising. We have to give the company a reasonable amount of time to get the needed sales to become a viable business. It would be hard to find any company that would have huge sales in their early going while they are still expanding distribution. I think this year will be most telling for the company and I am willing to see how things go through the first half of this year. If sales continue to increase at a reasonable rate, we will know we have a good long term winner.
If you take the time to review what this new management has accomplished in their first year and a half you would be truly amazed! Cheers!
News 
Market Data 
Discover 
AI
